|
韩 宁, 黄 强. 白细胞介素一6及其受体与胆管癌 [J]. 实用医学杂志, 2008(3):474.
|
|
Ferrari SL, Rizzoli R. Gene variants for osteoporosis and their pleiotropic effects in aging [J]. Molecular Aspects of Medicine, 2005.145.
|
|
Ershler W B, Keller E T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty [J]. Annual Review of Medicine, 2000.245.
|
|
Cacquevel M, Lebeurrier N, Cheenne S. Cytokines in neuroinflammation and Alzheimer's disease [J]. Current Drug Targets, 2004.529.
|
|
Miljkovic D J, Drulovic J, Trajkovic V. Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients [J]. European Journal of Neurology, 2002.413.
|
|
Nagatsu T, Sawada M. Inflammatory process in Parkinson's disease:role for cytokines [J]. Current Pharmaceutical Design, 2005.999.
|
|
Iacopetta B, Grieu F, Joseph D. The-174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype [J]. British Journal of Cancer, 2004.419.
|
|
Smith K C, Bateman A C, Fussell H M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis [J]. European Journal of Immunogenetics, 2004.167.
|
|
Van der Auwera I, Van Laere S J, Van den Eynden G G. Increased angiogenesis and lymphangiogenesis in inflammatory versus non-inflammatory breast cancer by real-time reverse transcnptase PCR gene expression quantification [J]. Clinical Cancer Research, 2004.7965.
|
|
Meng F, Henson R, Wehbe-Janek H. The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangioeytes [J]. Journal of Biological Chemistry, 2007.8256.
|
|
Tchirkov A, Khalil T, Chautard E. Interleukin-6 gene amplification and shortened survival in glioblastoma patients [J]. British Journal of Cancer, 2007.474.
|
|
De Vita F, Romano C, Orditura M. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator [J]. Journal of Interferon & Cytokine Research, 2001.45.
|
|
Barton B E, Murphy T F. Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen [J]. Cytokine, 2001.251.
|
|
Zaki M H, Nemeth J A, Trikha M. CNTO 328, a monoclonal antibody to IL-6 inhibits human tumor-induced cachexia in nude mice [J]. International Journal of Cancer, 2004.592.
|
|
Trikha M, Corringham R, Klein B. Targeted anti-interleukin-6 monoclonal antibody therapy for.cancer:a review of the rationale and clinical evidence [J]. Clinical Cancer Research, 2003.4653.
|
|
Bhardwaj A, Sethi G, Vadhan-Raj S. Resveratrol inhibits proliferation induces apoptosiS and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB--regulated anti-apoptotic and cell survival gene products in human multiple myeloma cells [J]. Blood, 2007.2293.
|
|
Lin M, Rose-John S, Grotzinger J, Conrad U Scheller J. Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants:purification via inverse transition cycling [J]. Biochemical Journal, 2006.577.
|
|
Kuroda K, Nakashima J, Kanao K. Interleukin 6 is associated with cachexia in patients with prostate cancer [J]. Urology, 2007.113.
|
|
Alberti L, Bachelot T, Duc A. A spliced isoform of interleukin-6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor [J]. Cancer Research, 2005.2.
|
下载:
苏公网安备 32100302010246号